• We apologize for the intermittent downtime on the site as we work through some technical difficulties.

Struggling Ionis licenses Bicycle Therapeutics' platform in a bid to develop drugs...

cafead

Administrator
Staff member
  • cafead   Jul 14, 2021 at 12:03: AM
via Attempting to rebound from setbacks earlier this year, Ionis has enlisted a new partner in a quest to create drugs that can cross the blood-brain barrier. And the technology comes from a British biotech primarily known for its efforts into oncology.

article source